Compare FSV & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSV | PTCT |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.7B |
| IPO Year | 2015 | 2006 |
| Metric | FSV | PTCT |
|---|---|---|
| Price | $139.94 | $83.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $208.25 | $80.65 |
| AVG Volume (30 Days) | 213.5K | ★ 1.9M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $264,734,000.00 |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $6.79 | $17.70 |
| P/E Ratio | $49.49 | ★ N/A |
| Revenue Growth | N/A | ★ 36.19 |
| 52 Week Low | $119.41 | $43.18 |
| 52 Week High | $205.99 | $87.50 |
| Indicator | FSV | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 68.32 |
| Support Level | $133.42 | $73.41 |
| Resistance Level | $157.74 | $87.50 |
| Average True Range (ATR) | 4.59 | 3.06 |
| MACD | -0.36 | 1.01 |
| Stochastic Oscillator | 65.00 | 79.99 |
FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.